The Serum Institute of India (SII) and UNICEF have entered into a long-term supply agreement for the AstraZeneca/Oxford and the Novavax vaccines, with the UN children’s agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries.

India is one of the world’s biggest drugmakers, and an increasing number of countries have already approached it for procuring the Coronavirus vaccines. “Today we are pleased to announce the conclusion of a long-term supply agreement with the Serum Institute of India for COVID-19 vaccines, to access two vaccine products through technology transfer from AstraZeneca and Novavax,” UNICEF Executive Director Henrietta Fore said.